Bank of America
EMMA

Bank of America’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Bank of America’s Portfolio EMMA Stock Details EMMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1
Closed – – 7707
2019
Q2 		$0 Buy
+1
New +$7 ﹤0.01% 7595
2019
Q1 		– Sell
-1
Closed – – 7613
2018
Q4 		$0 Sell
1
-47
-98% -$377 ﹤0.01% 7587
2018
Q3 		$0 Buy
48
+38
+380% +$377 ﹤0.01% 7605
2018
Q2 		$0 Sell
10
-49
-83% -$647 ﹤0.01% 7487
2018
Q1 		$0 Buy
59
+57
+2,850% +$923 ﹤0.01% 7476
2017
Q4 		$0 Hold
2
– – ﹤0.01% 7403
2017
Q3 		$0 Buy
+2
New +$47 ﹤0.01% 7413

Other funds holding EMMA

MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Bank of America's EMMA Position: Q3 2019 in Review

Bank of America sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2019, closing a stake of 1 share.

Bank of America first reported a position in EMMA in Q3 2017 and held it in 7 quarters. The position peaked at $0 in Q2 2019. 1 fund tracked by Wall St. Rank holds EMMA as of Q3 2019.

  • Bank of America reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Bank of America sold 1 Emmaus Life Sciences, Inc. Common Stock share in Q3 2019.
  • Bank of America first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
  • Bank of America's Emmaus Life Sciences, Inc. Common Stock position peaked at $0 in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2019.

Based on Bank of America's 13F filing for Q3 2019, filed 14 Nov 2019.